ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 676032 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 676032; 2) Community: the network communities that were significantly associated with the response to NSC 676032; 3) Molecule: the relationships between components within communities and NSC 676032; 4) MDR: the compounds that were significantly associated with the NSC 676032.

NSC Compound Enrichment Correlation
NSC 618296 Null 0.0407060322613564 0.025752129
NSC 644221 Null 0.0407060322613564 0.017698749
NSC 644582 Hydrazinecarboximidamide, 2-[(1H-indol-3-yl)methylene]- N-phenyl-, nitrate 0.0407060322613564 0.035533352
NSC 644961 Null 0.0407060322613564 0.11450835
NSC 646912 Null 0.0407060322613564 0.20307929
NSC 648365 Insulin-Methotrexate conjugate 0.0407060322613564 0.24602142
NSC 650931 2'-BROMO-4'-EPI-DAUNDRUBICIN 0.0407060322613564 0.1612175
NSC 657676 Null 0.0407060322613564 0.23996288
NSC 657751 Null 0.0407060322613564 0.093800699
NSC 661748 [6,6'-Bibenzo[6,7]cyclohepta[1,2,3-cd]benzofuran]-4,4',8,8', 10,10'-hexol, 1,1',6,6',7,7',11b,11'b-octahydro-1,1',7,7'- tetrakis(4-hydroxyphenyl)-, [1.alpha.,6.beta.(1'R*,6'S*,7'R*),7.alpha]- 0.0407060322613564 0.14123963
Total:67  Current:57    [First] [Prev] [Next] [Last]